1. Home
  2. TTAN vs EXAS Comparison

TTAN vs EXAS Comparison

Compare TTAN & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTAN
  • EXAS
  • Stock Information
  • Founded
  • TTAN 2012
  • EXAS 1995
  • Country
  • TTAN United States
  • EXAS United States
  • Employees
  • TTAN N/A
  • EXAS N/A
  • Industry
  • TTAN
  • EXAS Medical Specialities
  • Sector
  • TTAN
  • EXAS Health Care
  • Exchange
  • TTAN NYSE
  • EXAS Nasdaq
  • Market Cap
  • TTAN 10.2B
  • EXAS 10.7B
  • IPO Year
  • TTAN 2024
  • EXAS N/A
  • Fundamental
  • Price
  • TTAN $106.96
  • EXAS $51.91
  • Analyst Decision
  • TTAN Buy
  • EXAS Strong Buy
  • Analyst Count
  • TTAN 14
  • EXAS 20
  • Target Price
  • TTAN $122.38
  • EXAS $70.26
  • AVG Volume (30 Days)
  • TTAN 1.5M
  • EXAS 2.8M
  • Earning Date
  • TTAN 09-05-2025
  • EXAS 07-30-2025
  • Dividend Yield
  • TTAN N/A
  • EXAS N/A
  • EPS Growth
  • TTAN N/A
  • EXAS N/A
  • EPS
  • TTAN N/A
  • EXAS N/A
  • Revenue
  • TTAN $817,242,000.00
  • EXAS $2,828,128,000.00
  • Revenue This Year
  • TTAN $21.18
  • EXAS $14.58
  • Revenue Next Year
  • TTAN $13.86
  • EXAS $12.75
  • P/E Ratio
  • TTAN N/A
  • EXAS N/A
  • Revenue Growth
  • TTAN 28.01
  • EXAS 11.57
  • 52 Week Low
  • TTAN $79.81
  • EXAS $39.97
  • 52 Week High
  • TTAN $131.33
  • EXAS $72.83
  • Technical
  • Relative Strength Index (RSI)
  • TTAN N/A
  • EXAS 44.34
  • Support Level
  • TTAN N/A
  • EXAS $52.00
  • Resistance Level
  • TTAN N/A
  • EXAS $55.90
  • Average True Range (ATR)
  • TTAN 0.00
  • EXAS 2.31
  • MACD
  • TTAN 0.00
  • EXAS -0.04
  • Stochastic Oscillator
  • TTAN 0.00
  • EXAS 24.90

About TTAN SERVICETITAN INC

ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time. The Company also has subsidiaries in Yerevan, Armenia and British Columbia, Canada that primarily serve as research and development and support centers.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: